SEC Form D · filed January 8, 2024
MBF Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Thomas Tillett · Ambler, PAExec · DirectorChristopher M. Cashman · Ambler, PADirectorDhiren M. Thakker · Ambler, PADirectorAris M. Persidis · Ambler, PADirectorSherwin D. Jannat · New York, NYDirectorJohn D. Rutledge · New York, NYExec · DirectorGin N. Chao · Grand Cayman, Cayman IslandsDirectorJames Martin · San Diego, CADirectorJoseph Connor · New York, NYDirectorLorraine Keller · Ambler, PAExecRakesh Narasimhan · Seattle, WADirectorMarian Joh · Seattle, WAExec · DirectorNathan A. Lutz · Uniontown, PADirectorZachary K. Ellis · Pittsburgh, PADirectorJoseph Connor · New York, NYDirectorLorraine Keller · Ambler, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗